1-Hydroxybenzotriazole → (S)-5-chloro-N-(2'-methoxy-2-(2,2,2-trifluoroacetamido)-5H-spiro[oxazole-4,9'-xanthene]-7'-yl)picolinamide

HRID 1970311

Reaktionsgleichung

Reaktionsgleichung von HRID 1970311
[NH2:1][C:2]1[CH:15]=[CH:14][C:13]2[O:12][C:11]3[C:6](=[CH:7][C:8]([O:16][CH3:17])=[CH:9][CH:10]=3)[C@:5]3([CH2:21][O:20][C:19]([NH:22][C:23](=[O:28])[C:24]([F:27])([F:26])[F:25])=[N:18]3)[C:4]=2[CH:3]=1.[Cl:29][C:30]1[CH:31]=[CH:32][C:33]([C:36](O)=[O:37])=[N:34][CH:35]=1.Cl.CN(C)CCCN=C=NCC.ON1C2C=CC=CC=2N=N1>C(Cl)Cl.CN(C=O)C.O>[Cl:29][C:30]1[CH:31]=[CH:32][C:33]([C:36]([NH:1][C:2]2[CH:3]=[C:4]3[C:13]([O:12][C:11]4[CH:10]=[CH:9][C:8]([O:16][CH3:17])=[CH:7][C:6]=4[C@@:5]43[CH2:21][O:20][C:19]([NH:22][C:23](=[O:28])[C:24]([F:26])([F:25])[F:27])=[N:18]4)=[CH:14][CH:15]=2)=[O:37])=[N:34][CH:35]=1

Komponenten

8

Versuchsvorschrift

A 25 mL RBF containing a solution of (S)—N-(2′-amino-7′-methoxy-5H-spiro[oxazole-4,9′-xanthene]-2-yl)-2,2,2-trifluoroacetamide (0.058 g, 0.147 mmol), 5-chloropyridine-2-carboxylic acid (0.030 g, 0.190 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.045 g, 0.235 mmol) in DCM (4 mL) and DMF (0.25 mL) was treated with 1-hydroxy-1H-benzotriazole (0.014 g, 0.104 mmol) and stirred for 1.5 hrs at RT. The reaction was diluted with DCM (50 mL) and water (15 mL). The DCM layer was separated, dried over anhydrous sodium sulfate, and concentrated to dryness to yield (S)-5-chloro-N-(2′-methoxy-2-(2,2,2-trifluoroacetamido)-5H-spiro[oxazole-4,9′-xanthene]-7′-yl)picolinamide as a brownish solid. MS (ESI pos. ion) m/z: 533 (M+1).

Aufarbeitung

  1. customThe DCM layer was separated
  2. dry with materialdried over anhydrous sodium sulfate
  3. concentrationconcentrated to dryness

Quellen und Nachweise

ORD-Eintrag
ord-6a2c00154a3c4b01b359c35b1703783b
Quelldatensatz
uspto-grants-2013_04
Patentnummer
US08426447B2

Verknüpfte Notizen

Wird geladen…